<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>Etablissement Français du Sang (EFS)</institution>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>Gallian</surname>
    <given-names>Pierre</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award002">
  <funding-source>
   <institution>Alliance pour les sciences de la vie et de la santé (AVIESAN)</institution>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>de Lamballerie</surname>
    <given-names>Xavier</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award003">
  <funding-source>
   <institution>Institut National de la Santé et de la Recherche Médicale (INSERM)</institution>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>de Lamballerie</surname>
    <given-names>Xavier</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award004">
  <funding-source>
   <institution>European programmes PREDEMICS</institution>
  </funding-source>
  <award-id>FP7-n°278433</award-id>
  <principal-award-recipient>Rémi CHARREL</principal-award-recipient>
 </award-group>
 <award-group id="award005">
  <funding-source>
   <institution>European Virus Archive goes Global</institution>
  </funding-source>
  <award-id>EVAg, H2020-n°653316</award-id>
  <principal-award-recipient>
   <name>
    <surname>de Lamballerie</surname>
    <given-names>Xavier</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award006">
  <funding-source>
   <institution>European Network for Diagnostics of Imported Viral Diseases</institution>
  </funding-source>
  <principal-award-recipient>Rémi CHARREL</principal-award-recipient>
 </award-group>
 <funding-statement>This work was supported by Etablissement Français du Sang (EFS), Alliance pour les sciences de la vie et de la santé (AVIESAN), Institut National de la Santé et de la Recherche Médicale (INSERM) and in part by the European programmes PREDEMICS (FP7-n°278433), European Virus Archive goes Global (EVAg, H2020-n°653316) and European Network for Diagnostics of Imported Viral Diseases (ENIVD, European Centre for Disease Prevention and Control). The work of RC was done under the frame of EurNegVec COST Action TD1303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
